FDA approves Lupin’s Corgard generic

Press enter to search
Close search
Open Menu

FDA approves Lupin’s Corgard generic

By David Salazar - 10/09/2017

SILVER SPRING, Md. — The Food and Drug Administration has approved Lupin’s generic version of Corgard (nadolol) tablets. The drug is indicated to manage patients with angina pectoris and to treat hypertension.


Lupin’s generic will be available in 20-, 40- and 80-mg dosage strengths. The drug had U.S. sales of $109.8 million for the 12 months ended June 2017, according to QuintilesIMS data.


 


Related Topics